Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced that Astellas Pharma Inc. (TSE: ...
A muscle that no longer answers to the brain might sound useless. MIT researchers are trying to turn that idea into medicine.
Columbia University scientists developed a two-step RNA therapy that may repair cardiovascular tissue after a heart attack by ...
Following a research collaboration established in 2021, Astellas Pharma has reached an agreement to license a Dyno ...
Metabolic health is maintained through the complex interplay between key tissues, including adipose tissue, skeletal muscle, and the liver. Adipose tissue ...
Researchers have investigated the effect of increased cell temperature on the contractility of skeletal muscle and cardiac muscle by heating the muscle proteins using advanced microscopical techniques ...
Skeletal muscle loss is a risk factor for developing dementia, according to a study being presented today at the annual meeting of the Radiological Society of North America (RSNA). Skeletal muscles ...
Scientists have developed a specially formulated bioink, which contains microparticles engineered for sustained delivery of insulin-like growth factor-1 (IGF-1). This delivery enhances the formation ...
Sarcopenia, or muscle loss, is emerging as a major but overlooked health risk. Experts warn it worsens osteoporosis, ...